Gamma camera probe developer Neoprobe of Dublin, OH, this week reported that the company's net loss shrank in its third quarter (end-September 30) as revenues grew on stronger device sales.
For the period, Neoprobe reported sales of $2 million, more than doubling last year's revenue of $958,000 in the same quarter. The company turned in a net loss of $942,000 for the most recent quarter, compared with a net loss of $1.7 million in the same quarter of 2006.
Neoprobe said its results were helped by strong sales of its Bluetooth wireless probes, which helped offset a decline in sales of blood-flow devices.
By AuntMinnie.com staff writers
October 31, 2007
Related Reading
Neoprobe posts Q2 loss on higher sales, July 26, 2007
Neoprobe signs Cardinal for Lymphoseek sales, July 13, 2007
Neoprobe Lymphoseek trial progresses, June 21, 2007
Neoprobe's Q1 sales slip, loss edges up, May 1, 2007
Neoprobe Lymphoseek trial moves forward, March 5, 2007
Copyright © 2007 AuntMinnie.com
